Carregant...
Effect of lamivudine treatment on plasma levels of transforming growth factor β(1), tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B
AIM: Transforming growth factor (TGF)-β(1), metalloproteinase (MMP)-1 and its tissue inhibitor (TIMP)-1 are considered predictive biomarkers of chronic hepatitis activity and fibrosis. The aim of this study was to evaluate the effect of lamivudine treatment on the plasma levels of these peptides in...
Guardat en:
| Publicat a: | World J Gastroenterol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Baishideng Publishing Group Inc
2004
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4572189/ https://ncbi.nlm.nih.gov/pubmed/15309715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v10.i18.2661 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|